New GSP Regulations means Local Players Must Lift their Game
|
About Cold Chain Focus CHINA
|
|
The nature and the high value of the bio/pharmaceutical temperature controlled supply chain makes managing this very challenging and expensive process. China is at the point of becoming the largest biotechnology/pharmaceutical market globally but the country is still far from developing a comprehensive and efficient cold chain distribution system for bio/ pharmaceutical products and clinical trial supplies. Also, the environmental, structural and regulatory obstacles are also massive for bio/pharma companies in China.
Learn how China is meeting the challenges of Cold Chain in this resource centre
-
All I Want for Christmas is a Smooth Supply Chain! -
China Continues to Attract Biopharma -
Rapid Growth MENA Region Provides Opportunity for Businesses to Develop their Cold Chain Service Offerings -
Survey: Information in the Biopharma Supply Chain -
Examining the Nordic Pharmaceutical Supply Chain -
Outsourcing Provides the Opportunity for Innovative Solution Providers to Go Beyond Basic Freight Management -
The 2013 Cool Chain Excellence Awards - Nominate Now -
Discussing the Food Safety Modernization Act and e-Pedigree with Intelleflex’s Kevin Payne -
A Closer Look at Moog-Crossbow’s ILC-2000 Asset Tracking Solution -
ThermoSafe’s GreenBox Sets the Standard for Eco-Friendly Cold Chain Shipments
* = required.
-
Contributor: Cold Chain IQ -
Contributor: Cold Chain IQ -
Contributor: Andrea Charles -
Contributor: Cold Chain IQ -
Contributor: Huo Peiqiong -
Contributor: RuiQi Wang -
Contributor: Andrea Charles -
Contributor: Cold Chain IQ -
Contributor: Pharma IQ























Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!